About Hans Biomed
Hans Biomed is a company based in Seoul (South Korea) founded in 1993.. The company has 247 employees as of September 30, 2024. Hans Biomed operates in a competitive market with competitors including MiMedx Group, RevBio, Dimension Inx, PolyNovo and Gel4Med, among others.
- Headquarter Seoul, South Korea
- Employees 247 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hans Biomed Corp
-
Annual Revenue
$63.92 M (USD)10.65as on Sep 30, 2025
-
Net Profit
$-22.31 M (USD)-333.91as on Sep 30, 2025
-
EBITDA
$59 K (USD)-97.94as on Sep 30, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
247
as on Sep 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hans Biomed
Hans Biomed is a publicly listed company on the KRX with ticker symbol 042520 in South Korea, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Hans Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Hans Biomed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hans Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hans Biomed Comparisons
Competitors of Hans Biomed
Hans Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, RevBio, Dimension Inx, PolyNovo and Gel4Med, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
3D biomaterials are provided for regenerative medicine applications.
|
|
| domain | founded_year | HQ Location |
Developer of biodegradable temporising matrix for treating traumatic wounds
|
|
| domain | founded_year | HQ Location |
Gel4Med is focused on developing bioinspired medical solutions.
|
|
| domain | founded_year | HQ Location |
Protein-based retinal prosthesis for degenerative eye diseases is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hans Biomed
Frequently Asked Questions about Hans Biomed
When was Hans Biomed founded?
Hans Biomed was founded in 1993.
Where is Hans Biomed located?
Hans Biomed is headquartered in Seoul, South Korea.
Who is the current CEO of Hans Biomed?
Kim Geun-Young is the current CEO of Hans Biomed.
How many employees does Hans Biomed have?
As of Sep 30, 2024, the latest employee count at Hans Biomed is 247.
What is the annual revenue of Hans Biomed?
Annual revenue of Hans Biomed is $63.92M as on Sep 30, 2025.
What does Hans Biomed do?
Founded in 1993 in Seoul, South Korea, Hans Biomed operates in the biomaterials sector, with activities spanning allograft tissue, silicone polymers, medical devices, and biotechnology. Skin regeneration technologies have been developed, alongside bone transplant products for orthopedics, breast implants, scar treatments, face-lifting threads, and hair transplant devices. A self-skin cell treatment agent and a sol-gel drug delivery system for osteoporosis-related fractures are also produced.
Who are the top competitors of Hans Biomed?
Hans Biomed's top competitors include MiMedx Group, RevBio and Serigen.
Is Hans Biomed publicly traded?
Yes, Hans Biomed is publicly traded on KRX under the ticker symbol 042520.
What is Hans Biomed's ticker symbol?
The ticker symbol of Hans Biomed is 042520 on KRX.